Human Parvovirus B19: Molecular Virology, Clinical Features, Prevalence, Diagnosis and Control

Corcoran, A. and Doyle, Sean (2006) Human Parvovirus B19: Molecular Virology, Clinical Features, Prevalence, Diagnosis and Control. In: UNSPECIFIED Elsevier, pp. 173-209.

[img] Download (2MB)

Share your research

Twitter Facebook LinkedIn GooglePlus Email more...

Add this article to your Mendeley library


Parvovirus B19 (B19) is an erythrovirus and recent studies have classified B19 as a genotype 1 erythrovirus with genotypes 2 (erythrovirus K71 or A6) and 3 (erythrovirus V9) also present in the human population. B19 is a significant human pathogen which can cause foetal hydrops and foetal death if material infection, followed by transplacental foetal infection, occurs during pregnancy. The virus is also transmitted by inter-personal contact and potentially via blood product adminstration. Symptoms of B19 infection include malaise, rash and anthralgia. Significantly, maternal B19 infection during pregnancy can be asymptomatic and so careful monitoring of at-risk pregnancies is recommended. Both antibody- and cell-mediated immunity play an important role in the anti-viral response and effective diagnostic test systems, for both B19 antibody and DNA detection, are now available. B19-induced foetal hydrops can be effectively treated by intrauterine blood transfusion: however, no vaccine is available to prevent infection at present.

Item Type: Book Section
Keywords: Human Parvovirus; B 19; Molecular Virology; Clinical Features; Prevalence;
Academic Unit: Faculty of Science and Engineering > Biology
Item ID: 921
Depositing User: Dr. Sean Doyle
Date Deposited: 04 Mar 2008
Journal or Publication Title: Perspectives in Medical Virology
Publisher: Elsevier
Refereed: Yes

Repository Staff Only(login required)

View Item Item control page

Document Downloads

More statistics for this item...